Read more
Innovations in Cannabis Extracts Entice New Demographics
Interesting trends emerge when we examine the largest extract markets in the global cannabis industry. These trends suggest that innovations...
Read more
What Does the Future Hold for UK Cannabis?
After a recent conversation with Pierre van Weperen of Grow Group PLC and Grow Pharma, his vision of the United Kingdom’s...
Read more
EU verticals create new European MCOs: Multi-Country Operators
New European MCOs: Multi-Country Operators European cannabis markets are heating up, and virtually every country is buzzing about regulatory change...
Read more
The Best Global Cannabis Markets By Country 2023-2024
The global cannabis universe continues to expand rapidly after the United States Department of Health and Human Services (HHS) report, Germany’s removal...
Read more
The battle for Australian-grown cannabis: quality vs global price wars
There is a buzz around Australia about “Made in Australia” products, including cannabis. Every country should be proud of its...
Read more
What is Spain’s New Medical Cannabis Regulatory Framework?
Ultimately, patients deserve access to safer alternatives to current over-prescribed pharmaceutical medicines. Spain has become the latest large European country...
Read more
2024’s Hottest Global Medical Cannabis Market Trends
A massive dose of energy has jolted the global cannabis markets. The United States Department of Health and Human Services (HHS)...
Read more
Sassano: Why future EU medical cannabis branding is essential
Michael Sassano is a CEO and Chairman of the Board for SOMAÍ Pharmaceuticals, a leading EU-GMP European pharmaceutical and biotech...
Read more
Put Some Mint Terpenes In It
What is the first thing you do when you open a new bag of cannabis flower? You smell it! Cannabis...
Read more
Germany Leads The Global Medical Cannabis Explosion
The entire cannabis community is abuzz with German legalization. Not only is this a massive windfall for cannabis producers around the...
Read more
A Comparison Of Legal And Illicit EU Cannabis Markets
Co-Authored by Michael Sassano and Callum Kellas The cannabis illicit market existed in all countries long before the legal markets...
Read more
Pillar 2: German Cannabis Legalization is Moving Forward Fast
As if 2024 didn’t give the global medical cannabis enough with a 252-page report from the United States Department of Health and...
Read more
European Cannabis Q1 2024 Quarterly Update
2024 ushered in one of the most reformatory changes that the global medical cannabis community has ever witnessed. The EU...
Read more
Cannabis Rescheduling: DEA’s Decision Marks a New Era for the Industry
The US Drug Enforcement Administration (DEA) is set to approve the rescheduling of cannabis in a move set to have...
Read more
The Medical Cannabis Explosion Just Got Real
The global cannabis trifecta has hit! The United States has finally rescheduled cannabis, moving it to Schedule III; the Department...
Read more
Japanese Cannabis Reform Is Almost Here
In November 2023, the Japanese Ministry of Health, Labor and Welfare (MHLW) was tasked with developing rules and standards for THC levels...
Read more
Assessing Thailand’s Massive Cannabis Market Reality
The Thai cannabis market is currently a full-blown recreational model, and it has exploded quicker than any market in legal...
Read more
The Global Medical Cannabis Explosion Is Coming
Based in Lisbon, Portugal, Somai Pharmaceuticals is a large-scale, GMP-certified manufacturer and global supplier of cannabis products used in pharmacological...
Read more
When it comes to access, the rest of the world should follow Australia’s example
The Australian medical cannabis industry may have its challenges, but its focus on affordable access and patient care make it...
Read more
The Surging Tides Of Global Medical Cannabis Markets
You may not see it or even hear about it but have no doubts: an enormous regulatory framework tsunami pushing...
Read more
SOMAÍ Pharmaceuticals brings innovative product portfolio to Australia
European medicinal cannabis manufacturing powerhouse SOMAÍ Pharmaceuticals is set to shake up the Australian market with a range of products...
Read more
Ukraine joins global cannabis community
Now that Ukrainian President Volodymyr Zelenskiy has signed a law opening access to medical cannabis, Ukraine has joined a list of...
Read more
European Cannabis Q4 2023 Quarterly Update
U.S. and German Events Steer International Cannabis in 2024 As 2023 ended, all eyes remained glued on the United States Schedule...
Read more
Don’t get caught on the hop by HLVd
As Hop Latent Viroid is discovered in Australian cannabis crops for the first time, SOMAÍ Pharmaceuticals founder, chairman, and CEO Michael Sassano shares advice...
Read more
The Global Medical Cannabis Explosion is Imminent
Recently, I have become more optimistic about the global landscape of medical cannabis and the direction in which major regulatory...
Read more
2024 New Global Emerging Cannabis Markets Predictions
"As the entire cannabis world is abuzz and cannabis stocks are shooting through the roof with the potential United States...
Read more
Good or bad taste will make or break your cannabis product
When it comes to creating the ultimate cannabis brand, it’s all a matter of taste, says SOMAÍ Pharmaceuticals founder, chairman,...
Read more
US Cannabis Rescheduling Primed to Set Off a Global Cannabis Explosion
Written by Michael Sassano, CEO, Somai Pharmaceuticals. Published in Business of Cannabis. On January 12, the United States Department of Health and...
Read more
Looking to expand overseas? Here’s what you need to know
Cannabis has long been trending as a global product, providing regional players with the chance to expand into international markets. Somai...
Read more
Why 2024 Will Be the Best Year Yet for Cannabis Investment
Year over year, global cannabis revenues exceed expectations and now stand at an estimated $50 billion in global sales in...
Read more
How Australian Cannabis Brands Can Enter Europe
Cannabis has long been trending as a global product, providing regional players opportunities to reach outside their home countries and...
Read more
Ukraine Makes ‘Historic Decision’ to Legalise Medical Cannabis
“Ukraine is headed towards cannabis legalisation which will align themselves next to German cannabis reform. As pivotal as Ukraine is...
Read more
Ukraine Lawmakers Vote to Legalize Medical Marijuana
Ukraine’s parliament voted today to legalize medical marijuana. This vote comes after the war with Russia left thousands of people...
Read more
Ukraine Lawmakers Vote To Legalize Medical Cannabis
“Ukraine legalizing cannabis should be a signal to all countries that prohibit medicinal cannabis, that there are much worst things...
Read more
The Future of European Medical Cannabis Dispensaries
As Switzerland opens up its first cannabis dispensary, cannabis pharmacies in the European Union need to pay attention and look...
Read more
3 main contributors to the entourage effect for cannabis consumers to consider
There is much talk surrounding the "entourage effect" in the cannabis world. The entourage effect is the proposed idea that...
Read more
Q3 2023 European And US Cannabis Update
In the new edition of the "Q3 2023 European And US Cannabis Update," SOMAÍ Pharmaceuticals Founder and CEO Michael Sassano...
Read more
Four things to know for properly dosing oral cannabis formulations
As oral cannabis solutions become more popular, Michael Sassano CEO and founder of SOMAÍ Pharmaceuticals, explains how to get the...
Read more
The Advantages of Ethanol Extraction
Extraction technology is constantly evolving each year, which helps drive down associated costs, increase output volumes, and improve product quality....
Read more
Why white-labelled EU cannabis brands will fail
The European Union and global markets have invited the next cannabis disaster by disguising asset-poor brands as distributors and clinics....
Read more
SOMAÍ Pharmaceuticals Makes ‘Significant Step Towards Revenue Generation’ As Portuguese Market Heats Up
Last month, Portugal’s government announced plans to establish a working group to explore the regulation of adult-use cannabis, with a...
Read more
SOMAÍ Pharmaceuticals: recent developments in the eyes of Michael Sassano
SOMAÍ Pharmaceuticals is a large-scale manufacturer of cannabis products, focusing on the highest quality medical-grade uses. They separate and purify...
Read more
Crude FECO Vs Distillate Extracts: What Do Consumers Really Prefer?
Last week, Germany took the first step towards wholesale cannabis legalisation after the federal cabinet waved through the long-awaited draft...
Read more
Australian medical cannabis prioritises growing patient access
The Australian cannabis market is one of the largest, fastest-growing and most robust medical industries outside North America. Australia’s market...
Read more
How cannabis could help manage the unmet need in endometriosis
Endometriosis is a chronic inflammatory disorder that affects 10% of all women between the ages of 12 and 80 years...
Read more
What is Next After the German House Passes Cannabis Reform?
Last week, Germany took the first step towards wholesale cannabis legalisation after the federal cabinet waved through the long-awaited draft...
Read more
Europe’s current and future cannabis distribution models
Cannabis distribution companies in Germany and England received much attention and funding in early 2022. The growing revenue led investors to...
Read more
What are the barriers facing Spanish medical cannabis access?
Following another recent disappointment for Spanish patients, Michael Sassano, CEO and founder of SOMAÍ Pharmaceuticals explores the barriers preventing the...
Read more
From investor to innovator: Michael Sassano’s journey with SOMAÍ Pharmaceuticals
In a recent chat with Michael Sassano, the CEO of SOMAÍ Pharmaceuticals, we delved into the intricacies of the cannabis...
Read more
Albania Officially Green Lights Medical and Industrial Cannabis Cultivation
Albania has become the latest European country to officially legalise the ‘cultivation and processing of the cannabis plant and the...
Read more
European Cannabis Q2 2023 Quarterly Update
Country access schemes were simmering in the EU. Pressure continues to build from patients and advocates to increase access to...
Read more
WHAT IS THE CANNABIS EDGE IN GERMANY, AUSTRALIA, AND THE UK
Increasingly, global cannabis markets are moving toward regulated operations and have much to teach each other. Regulators around the world...
Read more
Who Was The Winner With German Recreational Light? Pharmaceutical Cannabis
Germany has finally come out with their proposed regulation, and the clear winner is pharmaceutical EU-GMP cultivators and manufacturers. April...
Read more
GMP# 18: Sales Planning for Pharmaceutical GMP Facilities
All startups, including new pharmaceutical manufacturing facilities, need to grapple with the complexities of launching. Pharmaceutical products are a considerable...
Read more
SOMAÍ Pharmaceuticals Announces Partnership with Releaf Clinic to Bring Innovative Cannabis Solutions to UK Patients
This collaboration marks the synergy of two vertically integrated fast-growing companies. SOMAÍ Pharmaceuticals is proud to announce a strategic partnership...
Read more
SOMAÍ Pharmaceuticals Launches in Ireland, Offering the Broadest Range of Cannabis-Based Medicines to Patients
SOMAÍ Pharmaceuticals ("SOMAÍ"), a leading EU-GMP vertically integrated Multi-Country Operator (MCO) company with a global footprint of distribution for the...
Read more
SOMAÍ Pharmaceuticals Launches in Ireland, Offering the Broadest Range of Cannabis-Based Medicines to Patients
SOMAÍ Pharmaceuticals ("SOMAÍ"), a leading EU-GMP vertically integrated Multi-Country Operator (MCO) company with a global footprint of distribution for the...
Read more
Global Cannabis: Michael Sassano, CEO and Founder at Somai Pharmaceuticals (AltMed Ep.117)
Watch the latest AltMed podcast, in which Michael Sassano and Andrew Dowling, AltMed's co-founder, discuss different aspects of the global...
Read more
Cosma S.A. and SOMAÍ Pharmaceuticals partner to Revolutionize Poland with the most Innovative Cannabis-Based Solutions
LISBON, PORTUGAL, August 29, 2024 - Cosma S.A., a leader in cannabis-based pharmaceutical advancements, and SOMAÍ Pharmaceuticals, a fully vertically...
Read more
Hanf Journal: Interview mit Michael Sassano, CEO von SOMAÍ Pharmaceuticals
Cannabis-Extrakte haben sich als vielversprechendes Therapeutikum in der modernen Medizin etabliert. Allerdings werden viele Anwenderinnen und Anwender vom Geschmack abgeschreckt,...
Read more
Hanf Journal: Interview mit Michael Sassano, CEO von SOMAÍ Pharmaceuticals
Cannabis-Extrakte haben sich als vielversprechendes Therapeutikum in der modernen Medizin etabliert. Allerdings werden viele Anwenderinnen und Anwender vom Geschmack abgeschreckt,...
Read more
ICBC News: Legal Global Cannabis Products Are Becoming More Diverse
As the legal cannabis industry continues to expand to nearly every corner of the planet, the variety of products available...
Read more
CannaReporter: SOMAÍ’s Journey to Global Leadership in Cannabinoid Extracts
SOMAÍ Pharmaceuticals is a leading EU-GMP European vertically integrated Multi-Country Operator (MCO) company with a global footprint of distribution for...
Read more
SOMAÍ Pharmaceuticals Expands Its Most Comprehensive Medicinal Cannabis Portfolio With Launch of New Mint Oral Solutions Line
SOMAÍ Pharmaceuticals ("SOMAÍ"), a fully vertically integrated Multi-Country Operator (MCO) in the global medical cannabis markets, is proud to announce...
Read more
Financial Times: European cannabis companies start IPO planning as US considers looser rules
A number of European cannabis start-ups are planning to go public in New York to take advantage of a US...
Read more
Cannabiz: SOMAÍ Pharmaceuticals ‘keeps promise’ to deliver expanded product range
SOMAÍ Pharmaceuticals is rolling out a suite of new products in Australia as it aims to back up its pledge...
Read more
Breaking Down Barriers to Medical Cannabis in the UK: Business of Cannabis
UK medical cannabis patients are facing multiple challenges that are preventing the adoption of the legal market. From stigmatisation and...
Read more
Medical Cannabis Goes Global: Michael Sassano of SOMAÍ reflects on UK launch (GC S2E7)
https://www.youtube.com/watch?v=tObqvfLA5lo&t=9s&ab_channel=GrowConversations Discussing a range of topics, including Michaels's background in setting up medical cannabis cultivation facilities in the US, The...
Read more
Leading Canadian Cannabis Brand Ghost Drops Enters into an Agreement with SOMAÍ Group for Global Distribution
The partnership opportunely positions Ghost Drops and SOMAÍ Group to succeed in the EU, UK, and Australian Cannabis Markets LISBON,...
Read more
Leading Canadian Cannabis Brand Ghost Drops Enters into an Agreement with SOMAÍ Group for Global Distribution
The partnership opportunely positions Ghost Drops and SOMAÍ Group to succeed in the EU, UK, and Australian Cannabis Markets LISBON,...
Read more
SOMAÍ Group, and its subsidiary, RPK Biopharma expand Cookies partnership to include Europe and the UK
SOMAÍ Group ("SOMAÍ") and its subsidiary, RPK Biopharma expanded their existing partnership with Cookies Creative Consulting & Promotions, Inc., a...
Read more
EU STARTUP NEWS: Reshaping EU’s Biopharma Industry: Is Cannabis the Future of Pharmaceutical Treatments?
While the boundaries of pharmaceuticals continue to expand with cutting-edge innovations, Lisbon-based company SOMAÍ Pharmaceuticals is trailblazing in the field...
Read more
Reshaping EU’s Biopharma Industry: Is Cannabis the Future of Pharmaceutical Treatments?
While the boundaries of pharmaceuticals continue to expand with cutting-edge innovations, Lisbon-based company SOMAÍ Pharmaceuticals is trailblazing in the field...
Read more
Portugal grows tonnes of medical cannabis for export but it remains out of reach for local patients
In 2023, Portugal exported 11 tonnes of cannabis but only 17 kg were sold within its borders. Patients still resort...
Read more
Euronews: Portugal grows tonnes of medical cannabis for export but it remains out of reach for local patients
“We’re a global company and as countries develop, we plug into that. We are still waiting for Portugal but it's...
Read more
SOMAÍ Pharmaceuticals Introduces UK to The Most Complete Cannabis-Based Product Portfolio Following a Distribution Deal
SOMAÍ Pharmaceuticals Signs Distribution Deal with Grow Pharma for UK’s Most Comprehensive Range of Cannabis-Based Medicines LISBON, PORTUGAL, March 12,...
Read more
SOMAÍ Pharmaceuticals brings innovative product portfolio to Australia
European medicinal cannabis manufacturing powerhouse SOMAÍ Pharmaceuticals is set to shake up the Australian market with a range of products...
Read more
SOMAÍ Pharmaceuticals Acquires RPK Biopharma (Holigen), Reinforcing Global Leading Position in Medicinal Cannabis Sector
This strategic acquisition enhances SOMAÍ's capacity with best-in-class cultivation, manufacturing, and distribution assets, making it one of the few verticals...
Read more
SOMAÍ Pharmaceuticals Introducing the U.S. Award-Winning Airo Brand to European and Australian Markets
SOMAÍ Pharmaceuticals announces its partnership with AIRO BRANDS, a U.S. multi-state CPG company focused on proprietary cannabis products. LISBON, PORTUGAL,...
Read more
The Mary Jane Society Podcast: Michael Sassano On Europe’s Cannabis Market
SOMAÍ Pharmaceutical‘s CEO Michael Sassano explores why the bill is a double edged sword, marking positive progress on one hand, but...
Read more
SOMAÍ Pharmaceuticals and Canify Announce Their Partnership to Introduce a Cannabinoid-Based Product Line in Germany
SOMAÍ Pharmaceuticals and Canify AG announce their strategic partnership to introduce a differentiated cannabinoid-based product line in Germany LISBON, PORTUGAL,...
Read more
SOMAÍ Pharmaceuticals Enters German Market with Strategic Partnerships Securing €10 Million 2-year Distribution Deal
SOMAÍ Pharmaceuticals announces two significant partnerships with Canymed GmbH and Grünhorn, as part of its entry into the German market....
Read more
SOMAÍ Pharmaceuticals is thrilled to partner with the groundbreaking medical cannabis study, T21
Launched in 2019 by Drug Science, and now over 4000 patients in, T21 is building the scientific evidence base for...
Read more
SOMAÍ Pharmaceuticals Signs Manufacturing Contract with Canna Forest
SOMAÍ Pharmaceuticals has signed a manufacturing agreement with Canna Forest to produce EU-GMP-certified extracted cannabis APIs and products at its...
Read more
SOMAÍ Pharmaceuticals Receives EU-GMP Certification and Raises €5 million
SOMAÍ Pharmaceuticals Unipessoal LDA, the largest European pharmaceutical cannabis product manufacturer, is pleased to announce that it has received authorisation...
Read more
SOMAÍ Pharmaceuticals has renewed the partnership with Lusófona University/CBIOS for formulation development
According to this partnership, Lusófona will develop lab-scale formulations and perform corresponding stability testing. The collaboration will also encompass "In...
Read more
Cannabis Biotech: Charting the Future of Scientific Discovery
Michael Sassano, the Founder of SOMAÍ Pharmaceuticals, discusses the latest advancements in cannabis biotechnology and explores the opportunities and challenges...
Read more
SOMAÍ Pharmaceuticals Signs Supply Contract with Cosma Cannabis
SOMAÍ Pharmaceuticals has entered into a two-year supply agreement with a well-respected Polish distributor Cosma Cannabis. Cosma produces medical-grade cannabis...
Read more
Global Whispers: A global market access journey in cannabinoid pharmaceuticals
Michael shares his company’s experiences bringing new products to market, the challenges SOMAÍ Pharmaceuticals have faced and the lessons the...
Read more
Glassroots Marketing Podcast: Pharmaceutical Cannabis and The Influence From Big Pharma
Grassroots Marketing discusses Pharmaceutical Cannabis and The Influence From Big Pharma with Michael Sassano, CEO of Somai Pharmaceuticals. Michael is the CEO...
Read more
Green Peak Podcast: Somai Pharmaceuticals LTD With Michael Sassano
Michael Sassano is one of the original movers and shakers in the cannabis industry. He was an early investor in...
Read more
42_Watch Out. Europe Is Gaining Ground Over The U.S. In Cannabis Medicine
Listen to Michael Sassano who is one of the most respected executives in the pharmaceutical cannabis space today. He was...